Association of Residual Cancer Burden After Neoadjuvant Therapy and Event-Free Survival in Breast Cancer

JAMA Oncol. 2022 Apr 1;8(4):1. doi: 10.1001/jamaoncol.2021.7997.

Authors

Xiaomei Huang¹, Zaiyi Liu²

Affiliations

¹ The Second School of Clinical Medicine, Southern Medical University, Guangzhou, China.
² Department of Radiology, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China.

PMID: 35201281
DOI: 10.1001/jamaoncol.2021.7997

No abstract available

Publication types

Comment

MeSH terms

Antineoplastic Combined Chemotherapy Protocols
Breast Neoplasms* / drug therapy
Chemotherapy, Adjuvant
Disease-Free Survival
Female
Humans
Neoadjuvant Therapy*
Neoplasm, Residual
Progression-Free Survival